SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-23-015482
Filing Date
2023-05-04
Accepted
2023-05-04 19:14:46
Documents
1
Period of Report
2023-05-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1522
  Complete submission text file 0001493152-23-015482.txt   3133
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 BELBROOK WAY ATHERTON CA 94027
Business Address
CASAMENTO CHARLES J (Reporting) CIK: 0001117167 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40023 | Film No.: 23890650